Literature DB >> 26488039

Rare diseases are a 'common' problem for clinicians.

Elizabeth Elliott1, Yvonne Zurynski.   

Abstract

BACKGROUND: Approximately 8% of the Australian population live with any one of about 10,000 known rare diseases. This is similar to the proportion of people living with diabetes or asthma.
OBJECTIVE: The aim of this article is to review the impact of rare diseases on families and health services, and the role of the general practitioner (GP) and policy response in Australia. DISCUSSION: Research from the Australian Paediatric Surveillance Unit indicates that people living with rare diseases face significant challenges, including diagnostic delays, lack of available treatment and difficulty in finding the right health service. Families feel isolated, under-supported, and often face economic hardship. All GPs see people with rare diseases and have a crucial role in making appropriate referrals, coordinating care, supporting families, and linking them with psychosocial and other supports. GPs require access to current, relevant resources to assist them to help patients with rare diseases. A coordinated national approach to rare diseases is also needed in Australia.

Entities:  

Mesh:

Year:  2015        PMID: 26488039

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  21 in total

1.  Cost-effectiveness analysis of gene-based therapies for patients with spinal muscular atrophy type I in Australia.

Authors:  Tianjiao Wang; Paul Scuffham; Joshua Byrnes; Martin Downes
Journal:  J Neurol       Date:  2022-08-18       Impact factor: 6.682

2.  Exploring deep learning methods for recognizing rare diseases and their clinical manifestations from texts.

Authors:  Isabel Segura-Bedmar; David Camino-Perdones; Sara Guerrero-Aspizua
Journal:  BMC Bioinformatics       Date:  2022-07-06       Impact factor: 3.307

3.  Living with a genetic, undiagnosed or rare disease: A longitudinal journalling study through the COVID-19 pandemic.

Authors:  Malia Byun; Hollie Feller; Monica Ferrie; Stephanie Best
Journal:  Health Expect       Date:  2022-02-05       Impact factor: 3.318

4.  Diagnosis of rare diseases under focus: impacts for Canadian patients.

Authors:  Daphne Esquivel-Sada; Minh Thu Nguyen
Journal:  J Community Genet       Date:  2017-07-21

5.  Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.

Authors:  Yvonne Zurynski; Marie Deverell; Troy Dalkeith; Sandra Johnson; John Christodoulou; Helen Leonard; Elizabeth J Elliott
Journal:  Orphanet J Rare Dis       Date:  2017-04-11       Impact factor: 4.123

Review 6.  Healthcare burden of rare diseases in Hong Kong - adopting ORPHAcodes in ICD-10 based healthcare administrative datasets.

Authors:  Annie Ting Gee Chiu; Claudia Ching Yan Chung; Wilfred Hing Sang Wong; So Lun Lee; Brian Hon Yin Chung
Journal:  Orphanet J Rare Dis       Date:  2018-08-28       Impact factor: 4.123

7.  Knowledge and Associated Factors about Rare Diseases among Dentists in Israel: A Cross Sectional Survey.

Authors:  Eitan Mijiritsky; Michal Dekel-Steinkeller; Oren Peleg; Shlomi Kleinman; Clariel Ianculovici; Amir Shuster; Shimrit Arbel; Menachem Ben-Ezra; Maayan Shacham
Journal:  Int J Environ Res Public Health       Date:  2021-06-25       Impact factor: 3.390

8.  Development of the parental needs scale for rare diseases: a tool for measuring the supportive care needs of parents caring for a child with a rare disease.

Authors:  Lemuel J Pelentsov; Andrea L Fielder; Thomas A Laws; Adrian J Esterman
Journal:  J Multidiscip Healthc       Date:  2016-09-09

9.  Rare disease: a national survey of paediatricians' experiences and needs.

Authors:  Yvonne Zurynski; Aranzazu Gonzalez; Marie Deverell; Amy Phu; Helen Leonard; John Christodoulou; Elizabeth Elliott
Journal:  BMJ Paediatr Open       Date:  2017-10-05

10.  Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries.

Authors:  Maria Kamusheva; Manoela Manova; Alexandra T Savova; Guenka I Petrova; Konstantin Mitov; András Harsányi; Zoltán Kaló; Kristóf Márky; Pawel Kawalec; Bistra Angelovska; Dragana Lakić; Tomas Tesar; Pero Draganic; Mary Geitona; Magdalini Hatzikou; Marian S Paveliu; Agnes Männik
Journal:  Front Pharmacol       Date:  2018-07-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.